NCT05828784尚未招募不适用
Italian Title:STUDIO CLINICO LONGITUDINALE, PROSPETTICO, PRE-CE PER LA VALUTAZIONE DELLA EFFICACIA E DELLA SICUREZZA DI UN CAGE INTERVERTEBRALE IN TITANIO ASSOCIATO AD UN SOSTITUTO OSSEO SINTETICO DI NATURA BIOCERAMICA NELLA NORMALE PRASSI CLINICA IN PROCEDURE DI FUSIONE INTERVERTEBRALE English Title: LONGITUDINAL, PROSPECTIVE, PRE-CE CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A TITANIUM INTERVERTEBRAL CAGE ASSOCIATED WITH A BIOCERAMIC SYNTHETIC BONE SUBSTITUTE IN NORMAL CLINICAL PRACTICE IN INTERVERTEBRAL FUSION PROCEDURES
SPS srl2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2023年12月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 35
- 试验地点
- 2
- 主要终点
- Bone fusion rate
研究概览
简要总结
Space clinical study aims to evaluate the performance, in terms of efficacy and safety of an intervertebral spacer associated with a bioceramic bone substitute in the context of intervertebral surgery for degenerative diseases.
Specifically, it is intended to evaluate:
- the capacity for bone regeneration/fusion, defined as absence of loosening and presence of continuous trabecular bone bridge in the absence of radiolucency lines, verified by imaging (CT) and evaluated according to the Brantingan scale;
- the safety of the medical device, through the incidence of any adverse events, complications, unexpected reactions, accidents;
- the improvement of clinical outcome in terms of pain and disability, at 9/14 months follow-up compared with preoperative scores, by clinical indices such as ODI and VAS.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who have provided hospital consent for surgical treatment;
- •Male patients and non-pregnant female patients between the ages of 18 and 75 years;
- •Patients requiring single-level interbody fusion in the L3-L4 and L4-L5 tract;
- •Patients with degenerative diseases of the spine, such as lumbar canal stenosis, lumbar discopathy, degenerative spondylolisthesis grade I;
- •Patients with a BMI <= 30;
- •Patients physically and mentally willing and able to comply with postoperative indications;
- •Patient able to understand the Italian language;
- •If the investigator decides to fuse an additional level for spinal stability during surgery, this is not an exclusion criterion; however, only one level will be measured to comply with the surgical indication.
- •Female patients who are pregnant or planning to become pregnant during the course of the study;
- •Obese patients with a BMI index > 30.
排除标准
- •Patients with:
- •systemic or localized infection;
- •Inflammatory or autoimmune disease;
- •hypercalcemia;
- •coagulation disorders;
- •metabolic disorders;
- •insulin-dependent diabetes;
- •alterations or complications of thyroid function;
- •overt allergy to calcium phosphate salts;
- •self-reported allergies to drugs and/or medical devices;
- •tumor and/or infectious diseases of the spine;
- •active neoplasms;
- •In addition, patients who:
- •Abuse alcohol and drugs;
- •Are affected by smoking (> 20 cigarettes/day);
- •Are on drug therapy that causes alteration of bone regeneration (e.g., chemotherapy);
- •already had surgery (revision surgery).
结局指标
主要结局
Bone fusion rate
时间窗: 9 months
the evaluation of the success rate in achieving bone fusion defined as bone regeneration/fusion capacity, understood as lack of loosening and presence of continuous trabecular bone bridge in the absence of radiolucency lines, verified by diagnostic imaging (CT) and evaluated according to the Brantingan scale;
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative DisordersRelapsed or Refractory Chronic Lymphoproliferative DisordersNCT01224769Gruppo Italiano Studio Linfomi109
尚未招募
不适用
RES-SAFE (Resorption, Safety, and Efficacy of Absorbable Collagen Membrane)Guided Bone RegenerationNCT06570265Hyundai Bioland Co., Ltd.50
已完成
不适用
Safety and Efficacy of an Intrastromal Transform Corneal Allograft (TCA) for Presbyopia Correction - Long Term Follow-upPresbyopiaNCT06310252Allotex, Inc.71
已完成
3 期
Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)Crohn's DiseaseNCT00805766Tanabe Pharma Corporation39
已完成
不适用
Clinical Investigation on the Use of Ophthalmic Solution Based on Sodium Hyaluronate in Treatment of Eye DiscomfortOcular DrynessNCT05777798SIFI SpA28
